BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29037039)

  • 1. Synthesis and Preclinical Evaluation of
    Xu X; Yuan L; Yin L; Jiang Y; Gai Y; Liu Q; Wang Y; Zhang Y; Lan X
    Mol Pharm; 2017 Nov; 14(11):3896-3905. PubMed ID: 29037039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of melanoma metastases with PET-Comparison of
    Wang Y; Li M; Zhang Y; Zhang F; Liu C; Song Y; Zhang Y; Lan X
    Nucl Med Biol; 2017 Jul; 50():33-38. PubMed ID: 28433794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging malignant melanoma with (18)F-5-FPN.
    Feng H; Xia X; Li C; Song Y; Qin C; Liu Q; Zhang Y; Lan X
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):113-122. PubMed ID: 26260649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanin-targeted preclinical PET imaging of melanoma metastasis.
    Ren G; Miao Z; Liu H; Jiang L; Limpa-Amara N; Mahmood A; Gambhir SS; Cheng Z
    J Nucl Med; 2009 Oct; 50(10):1692-9. PubMed ID: 19759116
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Wang Y; Li M; Zhang X; Ji H; Wang W; Han N; Li H; Xu X; Lan X
    Mol Pharm; 2023 Jan; 20(1):572-581. PubMed ID: 36382713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Rizzo-Padoin N; Chaussard M; Vignal N; Kotula E; Tsoupko-Sitnikov V; Vaz S; Hontonnou F; Liu WQ; Poyet JL; Vidal M; Merlet P; Hosten B; Sarda-Mantel L
    Nucl Med Biol; 2016 Dec; 43(12):773-780. PubMed ID: 27693672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance.
    Denoyer D; Greguric I; Roselt P; Neels OC; Aide N; Taylor SR; Katsifis A; Dorow DS; Hicks RJ
    J Nucl Med; 2010 Mar; 51(3):441-7. PubMed ID: 20150254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.
    Pyo A; Kim DY; Kim H; Lim D; Kwon SY; Kang SR; Kim HS; Bom HS; Min JJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12991-12999. PubMed ID: 32439710
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Pyo A; Kim HS; Kim HS; Yun M; Kim DY; Min JJ
    J Nucl Med; 2019 Jul; 60(7):924-929. PubMed ID: 30552204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted radiotherapy of pigmented melanoma with
    Xu X; Yuan L; Gai Y; Liu Q; Yin L; Jiang Y; Wang Y; Zhang Y; Lan X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):306. PubMed ID: 30537980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma.
    Wu SY; Huang SP; Lo YC; Liu RS; Wang SJ; Lin WJ; Shen CC; Wang HE
    Biomed Res Int; 2014; 2014():912498. PubMed ID: 25254219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel aliphatic 18F-labeled probe for PET imaging of melanoma.
    Liu H; Liu S; Miao Z; Jiang H; Deng Z; Hong X; Cheng Z
    Mol Pharm; 2013 Sep; 10(9):3384-91. PubMed ID: 23927458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-
    Garg PK; Nazih R; Wu Y; Singh R; Garg S
    J Nucl Med; 2017 May; 58(5):827-832. PubMed ID: 27980051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
    Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M
    J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.
    Rbah-Vidal L; Vidal A; Besse S; Cachin F; Bonnet M; Audin L; Askienazy S; Dollé F; Degoul F; Miot-Noirault E; Moins N; Auzeloux P; Chezal JM
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1449-61. PubMed ID: 22707183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy response monitoring of the early effects of a new BRAF inhibitor on melanoma xenograft in mice: evaluation of (18) F-FDG-PET and (18) F-FLT-PET.
    Geven EJ; Evers S; Nayak TK; Bergström M; Su F; Gerrits D; Franssen GM; Boerman OC
    Contrast Media Mol Imaging; 2015; 10(3):203-10. PubMed ID: 25204436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Preclinical Evaluation of a
    Wang T; Xu P; Fang J; Li C; Zeng X; Liu J; Meng L; Zhuang R; Zhang X; Su X; Guo Z
    Mol Pharm; 2023 Feb; 20(2):1015-1024. PubMed ID: 36562303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of a novel Al(18)F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma.
    Chang CC; Chang CH; Lo YH; Lin MH; Shen CC; Liu RS; Wang HE; Chen CL
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4133-9. PubMed ID: 27445169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of 18F-labeled picolinamide probes for PET imaging of malignant melanoma.
    Liu H; Liu S; Miao Z; Deng Z; Shen B; Hong X; Cheng Z
    J Med Chem; 2013 Feb; 56(3):895-901. PubMed ID: 23301672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumors.
    Garg S; Kothari K; Thopate SR; Doke AK; Garg PK
    Bioconjug Chem; 2009 Mar; 20(3):583-90. PubMed ID: 19222206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.